C20orf27 promotes hepatocellular carcinoma progression via NT5E

Yu He1,2, Wen Zhang1, Ming Chang3

  • 1School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.

Discover Oncology
|July 21, 2025
PubMed

Insights

This study identifies C20orf27 as a key driver of liver cancer. Upregulation of C20orf27 and NT5E indicates a poor prognosis for hepatocellular carcinoma patients.

Area of Science:

  • Molecular oncology
  • Hepatocellular carcinoma research

Background:

  • Liver cancer remains a leading cause of cancer mortality globally.
  • Effective therapeutic targets for liver cancer are limited, necessitating further research into novel molecular mechanisms.
  • The function of C20orf27, a gene on human chromosome 20, is not well understood.

Purpose of the Study:

  • To investigate the role of C20orf27 in liver cancer progression.
  • To identify downstream targets and potential biomarkers associated with C20orf27 in hepatocellular carcinoma (HCC).
  • To explore the prognostic significance of the C20orf27/NT5E axis in HCC.

Main Methods:

  • Analysis of C20orf27 expression in liver cancer samples.
  • Gain- and loss-of-function experiments to assess C20orf27's impact on cell proliferation and migration.
  • RNA sequencing, bioinformatics analysis, and immunohistochemistry to identify and validate downstream targets and clinical associations.

Main Results:

  • C20orf27 was found to be upregulated in liver cancer tissues.
  • C20orf27 promoted HCC cell proliferation and migration by regulating cell cycle proteins (MDM2, PCNA, Cyclin E1, CDK2, p-Rb).
  • NT5E was identified as a direct downstream target of C20orf27, and their combined high expression correlated with poorer patient survival.

Conclusions:

  • C20orf27 plays a critical role in promoting hepatocellular carcinoma progression.
  • The C20orf27/NT5E axis is a significant factor in HCC development and patient prognosis.
  • C20orf27 and NT5E represent potential novel therapeutic targets and prognostic biomarkers for liver cancer.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K